Here, we attempted to investigate the molecular mechanism by which highly expressed HTRA1 promotes the malignant phenotype of pancreatic tumor cells, as well as PanIN and PDAC progression in pancreatic tissues, and further provided a candidate drug for impeding pancreatitis-initiated PDAC through targeted inhibition of HTRA1. The gene discussed is HTRA1; the disease is pancreatitis.